CVS Caremark Corporation - SWOT Analysis

CVS Caremark Corporation - SWOT Analysis
  • Report price : $ 125
  • Publication date : August 2008
  • Length : 27 pages

Get this Report Now !

CVS Caremark Corporation - SWOT Analysis

Datamonitor's CVS Caremark Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

CVS Caremark operates in the US retail drugstore industry. The company sells prescription drugs and an assortment of general merchandise. The company also provides a range of prescription benefit management services to managed care and other organizations. The company operates primarily in the US. It is headquartered in Woonsocket, Rhode Island and employs about 200,000 people. The company recorded revenues of $76,329.5 million in the financial year (FY) ended December 2007, an increase of 74.2% over 2006. The operating profit of the company was $4,793.3 million in FY2007, an increase of 96.3% over 2006. The net profit was $2,622.8 million in FY2007, an increase of 93.6% over 2006.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

RELATED REPORTS

ViroPharma Incorporated - SWOT Analysis

ViroPharma Incorporated - SWOT Analysis

  • $ 125
  • August 2008
  • 24 pages

Datamonitor's ViroPharma Incorporated - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strat ...

Industries : Healthcare

Snapshots US Healthcare Services 2008

Snapshots US Healthcare Services 2008

  • $ 600
  • August 2008
  • 14 pages

Snapdata's Snapshots US Healthcare Services 2008 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US healthcare service market and covers government-funded, private payments, privat ...

Industries : Healthcare

Apria Healthcare Group Inc. - SWOT Analysis

Apria Healthcare Group Inc. - SWOT Analysis

  • $ 125
  • July 2008
  • 26 pages

Table of Contents:This product typically includes the following sections:Key Facts Company Overview Business Description Company History Key Employees Key Employee Biographies Company View SWOT analysis Products & Services Listing Products & Services Analysis ...

Industries : Healthcare

Nastech Pharmaceutical Company Inc - SWOT Analysis

Nastech Pharmaceutical Company Inc - SWOT Analysis

  • $ 125
  • July 2008
  • 25 pages

Table of Contents:This product typically includes the following sections:Key Facts Company Overview Business Description Company History Key Employees Key Employee Biographies Company View SWOT analysis Products & Services Listing Products & Services Analysis ...

Industries : Healthcare

Biomet, Inc. - SWOT Analysis

Biomet, Inc. - SWOT Analysis

  • $ 125
  • July 2008
  • 25 pages

Table of Contents:This product typically includes the following sections:Key Facts Company Overview Business Description Company History Key Employees Key Employee Biographies Company View SWOT analysis Products & Services Listing Products & Services Analysis ...

Industries : Healthcare

Bayer AG - SWOT Analysis

Bayer AG - SWOT Analysis

  • $ 125
  • August 2008
  • 37 pages

Datamonitor's Bayer AG - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Bayer is a ...

Industries : Healthcare

Cerner Corporation - SWOT Analysis

Cerner Corporation - SWOT Analysis

  • $ 125
  • August 2008
  • 29 pages

Datamonitor's Cerner Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ...

Industries : Healthcare

E. I. duPont de Nemours & Company - SWOT Analysis

E. I. duPont de Nemours & Company - SWOT Analysis

  • $ 125
  • August 2008
  • 33 pages

Datamonitor's E. I. duPont de Nemours & Company - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines ...

Industries : Healthcare

Cubist Pharmaceuticals, Inc. - SWOT Analysis

Cubist Pharmaceuticals, Inc. - SWOT Analysis

  • $ 125
  • August 2008
  • 29 pages

Datamonitor's Cubist Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and ...

Industries : Healthcare

Forecast Insight: Antihypertensives  Key patent expiries prevent market growth

Forecast Insight: Antihypertensives Key patent expiries prevent market growth

  • $ 15 200
  • July 2008
  • 96 pages

IntroductionDatamonitor expects the antihypertensives market to reach $37 billion, across the seven major markets, by 2017. The growth will be driven by the uptake of Novartis's Tekturna, as well as increased use of ARBs, and their combinations. However, the expiries of some key patents, particularl ...

Industries : Healthcare

24/7 Customer Service

Contact Shadi now !

Related industries

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.